Mineralys Therapeutics
Radnor
About Mineralys Therapeutics
Mineralys Therapeutics is a biopharmaceutical company that provides hypertension treatment. They also bring a targeted approach to the management of hypertension.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $740.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: nasdaq:MLYS
- Website: mineralystx.com
- Phone: +1 610 977 2000
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/mineralys-therapeutics-75948 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.